Bluejay Diagnostics, Inc. Cash and Cash Equivalents
Bluejay Diagnostics, Inc. (BJDX) had Cash and Cash Equivalents of $9.60 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $9.60M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $3.68M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $5.16M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $3.08M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $9.60M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $3.68M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $5.16M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $3.08M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $4.44M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $3.12M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $4.30M 10-K · filed 2026-03-06 |
| 2024-09-30 | $5.76M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $8.06M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.66M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.21M 10-K · filed 2025-03-31 |
| 2023-09-30 | $5.08M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.10M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $6.78M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $10.11M 10-K · filed 2024-03-28 |
| 2022-09-30 | $13.29M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $15.34M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $17.12M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $19.05M 10-K · filed 2023-03-20 |
| 2021-09-30 | $2.33M 10-Q · filed 2021-12-16 |
| 2020-12-31 | $912.36K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |